CALIWAY BIOPHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 675.00 TWD | +5.63% |
|
+6.30% | +9.76% |
| Jan. 08 | Caliway Biopharmaceuticals Co., Ltd.(TWSE:6919) added to Taiwan TAIEX Index | CI |
| Dec. 12 | Caliway Biopharmaceuticals' Fat Reduction Drug Meets Efficacy Endpoints | MT |
Chart calendar Caliway Biopharmaceuticals Co., Ltd.
3bd16b.RWHXqZAdp-wZhUcpEJaQt-sagwKL-N9I3EbH2UwgHtM.KDGv_ult5aRw83FcXN7ewNhUzXTGq4ABmnSGqDsZVJokLa_75Hjmu2zQcw~02059bd242f498582a6bceac129515b3
Upcoming events on Caliway Biopharmaceuticals Co., Ltd.
Past events on Caliway Biopharmaceuticals Co., Ltd.
| 2025-01-08 03:17 am | December 2024 Sales and Revenue Release |
| 2024-12-18 01:00 am | Yuanta Securities Investor Conference |
| 2024-12-04 02:06 am | November 2024 Sales and Revenue Release |
| 2024-11-07 | Q3 2024 Earnings Release |
| 2024-11-06 02:13 am | October 2024 Sales and Revenue Release |
| 2024-10-08 04:12 am | September 2024 Sales and Revenue Release |
| 2024-09-09 04:18 am | August 2024 Sales and Revenue Release |
| 2024-08-13 05:11 am | Q2 2024 Earnings Release |
| 2024-08-06 04:30 am | July 2024 Sales and Revenue Release |
| 2024-06-15 02:45 pm | BIO International Convention |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 | 43,0 | 3 041 | 5 910 |
|
EBITDA Million TWD | Released Forecast Spread | 0,00 | -629 | 2 250 | 5 055 |
|
EBIT Million TWD | Released Forecast Spread | 0,00 | -788 | 1 949 | 4 804 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -488 | -707 | -940 | -890 |
|
Net income Million TWD | Released Forecast Spread | -488 | -707 | -940 | -890 |
|
EPS TWD | Released Forecast Spread | 0,00 | -4,61 | -6,13 | -5,80 |
| Announcement Date | 04/03/24 | - |
Quarterly results
| Fiscal Period | September | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 23,3 12,0 93.81% | 8,00 | 4,00 | 8,00 | 10,0 | 3 019 | 20,0 | 21,0 |
|
EBIT Million TWD | Released Forecast Spread | -153 -218 29.75% | -200 | -248 | -238 | -285 | 2 719 | -238 | -235 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -138 -201 31.56% | -175 | -241 | -230 | -277 | -215 | -225 | -222 |
|
Net income Million TWD | Released Forecast Spread | -138 -201 31.56% | -175 | -241 | -230 | -277 | -215 | -225 | -222 |
|
EPS TWD | Released Forecast Spread | -0,99 -1,31 24.43% | -1,14 | -1,57 | -1,50 | -1,80 | -1,40 | -1,47 | -1,45 |
| Announcement Date | 13/11/24 | - | - | - | - | - | - | - |
More events
Past sector events for Caliway Biopharmaceuticals Co., Ltd.
| Today | AARTI PHARMALABS LIMITED: Q3 2025 Earnings Release (Projected) |
| 2025-01-10 07:00 am | TILRAY BRANDS, INC.: Q2 2025 Earnings Release |
| 2025-01-10 04:09 am | LOTUS PHARMACEUTICAL CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 06:50 pm | BORA PHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2025-01-09 05:25 am | SCINOPHARM TAIWAN, LTD.: December 2024 Sales and Revenue Release |
| 2025-01-08 | HISAMITSU PHARMACEUTICAL CO., INC.: Q3 2024 Earnings Release |
| 2025-01-08 03:17 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: December 2024 Sales and Revenue Release |
| 2024-12-10 11:45 am | MEDINCELL S.A.: Q2 2025 Earnings Release |
| 2024-12-10 04:02 am | LOTUS PHARMACEUTICAL CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-10 01:29 am | CENTER LABORATORIES, INC.: November 2024 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 6919 Stock
- Calendar Caliway Biopharmaceuticals Co., Ltd.